Open letter to Roche about oseltamivir trial data
- 29 October 2012
- Vol. 345 (oct29 2) , e7305
- https://doi.org/10.1136/bmj.e7305
Abstract
Roche promised in 2009 to release full reports from clinical trials of oseltamivir in response to an investigation by the BMJ and the Cochrane Collaboration. In this open letter to John Bell, regius professor of medicine at Oxford University and a Roche board member, the BMJ’s editor in chief further urges the company to disclose the full dataKeywords
This publication has 7 references indexed in Scilit:
- Complications: tracking down the data on oseltamivirBMJ, 2009
- Point-by-point response from Roche to BMJ questionsBMJ, 2009
- Neuraminidase inhibitors--the story behind the Cochrane reviewBMJ, 2009
- Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysisBMJ, 2009
- Impact of Oseltamivir Treatment on Influenza-Related Lower Respiratory Tract Complications and HospitalizationsArchives of internal medicine (1960), 2003
- Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trialThe Lancet, 2000
- Efficacy and Safety of the Oral Neuraminidase Inhibitor Oseltamivir in Treating Acute InfluenzaJAMA, 2000